Index overviewEvent timeline

KEDI U.S. Dividend100 90% Participation + Daily Options Premium Index

Enhanced income with dividends and NDX call premiums combined.

Recent events

54 of 54
Oct 8, 2026
PepsiCo Inc (PEP)
Earnings Release

Q3 2026 earnings release on October 8, 2026, is scheduled; Medium importance is estimated based on typical price volatility during earnings reports.

Sep 29, 2026
Paychex Inc. (PAYX)
Earnings Release

Paychex's Q1 fiscal 2027 earnings release is estimated based on past reporting schedules; earnings releases typically cause significant price volatility, justifying a medium importance estimate, and is scheduled.

Sep 24, 2026
NIKE Inc (NKE)
Earnings Release

NIKE, Inc. is scheduled to report its fiscal 2027 first-quarter earnings on September 24, 2026; importance is estimated at Low as it is a standard quarterly release with expected impact of ≥1%, scheduled.

Aug 27, 2026

Q2 2026 earnings release is scheduled. Medium importance is estimated as earnings reports typically drive significant price movement. Analysts forecast EPS of ~$3.80-3.88 forecasted.

Aug 27, 2026
Best Buy Co Inc (BBY)
Earnings Release

Q2 FY2027 earnings release on August 27, 2026. Low importance estimated for the announcement of the date itself, scheduled.

Aug 18, 2026

Q2 2026 earnings release scheduled for 2026-08-18. Analysts forecast EPS of approximately $4.71-$4.73 and revenue around $47.5 billion, scheduled. High importance estimated due to potential for significant price impact.

Aug 4, 2026
Devon Energy Corp (DVN)
Earnings Release

Devon Energy is scheduled to release its Q2 2026 earnings results after the market closes on August 4, 2026. Analysts forecast EPS of approximately $1.27-$1.34. This is the first report post-Coterra merger, likely causing >10% price impact, scheduled.

Aug 4, 2026
EOG Resources Inc. (EOG)
Earnings Release

Q2 2026 earnings release scheduled for 2026-08-04, with a conference call on 2026-08-05. High importance is assigned as earnings releases typically drive significant volatility. Scheduled.

Aug 4, 2026
Amgen Inc (AMGN)
Earnings Release

Amgen is scheduled to report its Q2 2026 financial results after the market closes on August 4, 2026; analysts forecast an EPS of approximately $5.57-$5.60. This event is assigned Medium importance as earnings reports typically cause price shifts of 5% or more scheduled.

Aug 4, 2026
Sysco Corporation (SYY)
Earnings Release

Sysco's Q4 and full fiscal year 2026 earnings results on 2026-08-04. Market impact is expected to be medium as investors assess the company's full-year performance scheduled.

Aug 4, 2026
Merck and Co Inc (MRK)
Earnings Release

Merck to release its second-quarter 2026 financial results on August 4, 2026, before the market opens; low impact expected.

Jul 31, 2026
Chevron Corp (CVX)
Earnings Release

Chevron's Q2 2026 earnings release is scheduled for July 31, 2026. This will be a key update on financial performance and the ongoing integration of Hess assets. Estimated price impact is medium (5-7%) based on historical earnings volatility scheduled

Jul 31, 2026

T. Rowe Price is scheduled to release its Q2 2026 financial results on July 31, 2026. Analysts forecast earnings changes, and the release typically impacts price by 5-7%, justifying a Medium importance scheduled.

Jul 31, 2026

As quarterly results typically drive significant price movement, Medium importance is estimated for the Q2 2026 earnings release and conference call scheduled.

Jul 30, 2026

Bristol Myers Squibb is scheduled to announce its financial results for the second quarter of 2026 on July 30, 2026, before the market opens, followed by a conference call with executives. This is a recurring event with the potential for moderate stock price volatility based on results and guidance. This event is scheduled.

Jul 30, 2026
The Cigna Group (CI)
Earnings Release

The Cigna Group is scheduled to release its second quarter 2026 financial results on July 30, 2026. Estimated Medium impact as earnings reports typically drive significant volatility, scheduled.

Jul 29, 2026

Fourth quarter and full-year fiscal 2026 earnings results are scheduled to be released before the market opens on July 29, 2026. A significant market reaction is possible, as the previous earnings report on April 29, 2026, was followed by an 8% stock price increase, scheduled.

Jul 29, 2026

Procter & Gamble is scheduled to release its Q4 and full-year fiscal 2026 earnings results on July 29, 2026, before the market opens. Analysts forecast an adjusted EPS of $1.42, a decrease from the prior year, and the options market implies a potential stock price move of approximately 5.0% following the announcement, scheduled.

Jul 28, 2026

Q2 2026 earnings release on 2026-07-28. Importance is High as actual results versus forecasts can cause significant price volatility, scheduled.

Jul 28, 2026
Coca-Cola Co (The) (KO)
Earnings Release

The Coca-Cola Company is scheduled to release its Q2 2026 financial results on July 28, 2026, before the market opens. Analysts forecast EPS of approximately $0.92-$0.93. A Medium importance is estimated as earnings releases typically impact price by 5-10%, scheduled.

Jul 28, 2026

Mondelez International will release its Q2 2026 financial results on July 28, 2026, scheduled. Price impact is estimated at Medium (~5%) as quarterly earnings releases typically drive significant market volatility.

Jul 28, 2026

United Parcel Service (UPS) is scheduled to announce its 2026 second-quarter results on July 28, 2026; with analysts forecasting EPS of $1.65, Medium importance is estimated as earnings typically drive >5% volatility scheduled.

Jul 28, 2026

Ex-dividend date for a regular quarterly cash dividend of $1.19 per share on 2026-07-28. The dividend was declared on July 16, 2026, and is payable on August 28, 2026.

Jul 27, 2026

Lakeland Financial is scheduled to release its Q2 2026 earnings before the market opens on July 27, 2026; analysts forecast earnings of $1.07 per share and revenue of $72.11 million. Medium importance is estimated as earnings releases typically result in ≥5% price volatility scheduled.

Jul 24, 2026
SLB Ltd (SLB)
Earnings Release

SLB is scheduled to release its Q2 2026 earnings results before the market opens on July 24, 2026, with a conference call to follow. This is a future event, scheduled.

Jul 24, 2026

Booz Allen Hamilton is scheduled to report its Q1 Fiscal Year 2027 earnings on July 24, 2026. Analysts forecast earnings of $1.49 per share on revenue of $2.81 billion, scheduled. (Estimated impact: Neutral as the market typically prices in consensus forecasts).

Jul 23, 2026
Comcast Corp (CMCSA)
Earnings Release

Comcast is scheduled to report its Q2 2026 financial results and host a conference call on July 23, 2026. This is a significant recurring event for investors, scheduled.

Jul 23, 2026

Q2 2026 earnings release scheduled before market open on July 23, 2026. Analysts forecast revenue of approximately $19.5 billion and EPS of $7.28. High importance due to potential for significant price volatility following the report, scheduled.

Jul 23, 2026
Blackstone Inc (BX)
Earnings Release

Blackstone is scheduled to announce its Q2 2026 financial results on July 23, 2026; analysts forecast EPS of $1.31-$1.35 and revenue of $3.34-$3.42 billion. A ~5% price impact is estimated based on historical volatility around earnings. scheduled

Jul 23, 2026

The ex-dividend date for a quarterly cash dividend of $0.990 per share is on July 23, 2026. This represents a 10% increase from the previous dividend of $0.900 per share, as announced on July 8, 2026. The dividend is payable on August 14, 2026. Medium importance is estimated as a double-digit dividend increase is a positive signal for investors.

Jul 22, 2026
CME Group Inc (CME)
Earnings Release

CME Group is scheduled to announce its earnings for the second quarter of 2026 before the market opens on July 22, 2026, with analysts forecasting EPS around $2.98 scheduled. High importance is estimated as earnings reports typically result in significant market volatility.

Jul 22, 2026

Preferred Bank is scheduled to release its Q2 2026 financial results before the market opens on July 22, 2026. Analysts forecast EPS of approximately $2.66 on revenues of $73.6 million. A price impact of ≥5% is estimated as earnings reports typically drive significant market volatility; scheduled.

Jul 21, 2026

Marsh & McLennan is scheduled to report its Q2 2026 financial results before the market opens on July 21, 2026, followed by an investor conference call. Analysts forecast earnings of approximately $2.88-$2.90 per share on revenues of about $7.27-$7.28 billion, which would represent year-over-year growth. This event is scheduled. High importance is estimated as earnings results often drive significant price movement.

Jul 21, 2026
Bank OZK (OZK)
Earnings Release

Bank OZK is scheduled to release second-quarter 2026 earnings after the market close on July 21, 2026, expected.

Jul 20, 2026

Blackstone announced an agreement to acquire a controlling stake in Futronic Co. for approximately $720 million on July 20, 2026.

Jul 20, 2026

On July 20, 2026, Chevron shut down production at its Petronius facility in the U.S. Gulf of Mexico as a precautionary measure ahead of Tropical Depression Two. The platform has a production capacity of around 60,000 barrels of oil per day. Estimated price impact is low (<2%) as this represents a small portion of total production.

Jul 17, 2026

Announced an agreement to acquire a 42% interest in a BP subsidiary to redevelop four producing oil fields in the Kirkuk area of northern Iraq, with an effective date of July 1, 2026. The deal adds over 3 billion barrels of oil equivalent in recoverable resources.

Jul 17, 2026

Regions Financial reported Q2 2026 results on July 17, 2026, with adjusted diluted EPS of $0.68, beating analyst estimates of $0.63-$0.65. Total revenue was approximately $1.91 billion. (Medium importance estimated based on positive earnings surprise).

Jul 16, 2026

Reported Q2 2026 earnings with adjusted EPS of $1.31, beating estimates of ~$1.28. Revenue was ~$12.5 billion, slightly missing estimates. The company raised its full-year 2026 adjusted EPS guidance to $5.45-$5.60. The stock rose over 11% in pre-market trading.

Jul 16, 2026

The U.S. FDA approved Lipfendra (enlicitide) on July 16, 2026, as the first once-daily oral PCSK9 inhibitor; high impact expected due to first-in-class status.

Jul 16, 2026

UnitedHealth Group reported Q2 2026 earnings per share (EPS) of $6.38, significantly beating analyst consensus estimates of approximately $4.94. Revenue for the quarter was $112.03 billion, also exceeding expectations. The company raised its full-year 2026 guidance.

Jul 16, 2026

On July 16, 2026, the company announced its subsidiary, fairlife, LLC, experienced a ransomware attack, leading to a temporary suspension of its U.S. production operations. The full scope and impact are under investigation.

Jul 16, 2026

As part of a broader national retail strategy and restructuring plan initiated in April 2026, Nike closed two retail stores in Cary, NC, and San Jose, CA, on July 16, 2026.

Jul 15, 2026

Awarded a 12-year contract with a ceiling of $10.5 billion to provide global logistics and sustainment support for U.S. Special Operations Command (USSOCOM). High importance due to the large contract value exceeding 10% of annual revenue.

Jul 15, 2026

Announced a 13% increase in the quarterly common stock dividend to $0.30 per share on July 15, 2026, payable on October 1, 2026. (Medium importance estimated based on double-digit dividend growth).

Jul 14, 2026

Merck's partner Kelun-Biotech announced on July 14, 2026, that a Phase 3 trial of sac-TMT with KEYTRUDA met its primary endpoint; medium impact expected as it strengthens the oncology pipeline.

Jul 14, 2026

Announced a strategic alliance with Liberty Energy to provide modular infrastructure and integrated power solutions for data center projects on July 14, 2026, aiming to address the high-growth AI infrastructure market.